Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saakshi Medtech and Panels's earnings before interest and taxes (EBIT) for the
six
months ended in Mar. 2026 was ₹89.2 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹89.2 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Saakshi Medtech and Panels's annualizedROC % for the quarter that ended in Mar. 2026 was 9.59%.
Saakshi Medtech and Panels's annualizedROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 14.81%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Saakshi Medtech and Panels's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.41%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Electrical Equipment & Parts subindustry, Saakshi Medtech and Panels's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saakshi Medtech and Panels EV-to-EBIT vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Saakshi Medtech and Panels's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Saakshi Medtech and Panels's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹89.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saakshi Medtech and Panels (NSE:SAAKSHI) has a EBIT of ₹89.2 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Saakshi Medtech and Panels.
Is Saakshi Medtech and Panels' EBIT too high?
Saakshi Medtech and Panels' current EBIT is ₹89.2 Mil. Overall, Saakshi Medtech and Panels has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Saakshi Medtech and Panels' EBIT compare to VRT and BE?
Saakshi Medtech and Panels' EBIT of ₹89.2 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Industrial Products company?
A good EBIT depends on the Industrial Products industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Saakshi Medtech and Panels. Saakshi Medtech and Panels's current EBIT is ₹89.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saakshi Medtech and Panels stock overvalued right now?
Based on GuruFocus' analysis, Saakshi Medtech and Panels (NSE:SAAKSHI) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹220.57, compared to a current price of ₹345.40 — trading 56.6% above its estimated fair value. The current EBIT is ₹89.2 Mil. Saakshi Medtech and Panels' overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Saakshi Medtech and Panels (NSE:SAAKSHI), the current EBIT is ₹89.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saakshi Medtech and Panels (NSE:SAAKSHI) Overvalued in 2026?
Based on GuruFocus' analysis, Saakshi Medtech and Panels stock appears to be overvalued.
The current stock price of ₹345.40 is trading 56.6% above its estimated GF Value™ of ₹220.57.
GuruFocus considers Saakshi Medtech and Panels to be Significantly Overvalued.
Key valuation signals for NSE:SAAKSHI:
EBIT: ₹89.2 Mil
GF Value™: ₹220.57 vs. price of ₹345.40 (56.6% above fair value)
No single metric tells the full story. See the NSE:SAAKSHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saakshi Medtech and Panels Ltd is a diversified company engaged in manufacturing Electrical Control Panels and Cabinets used in elevators, air compressors, renewable energy industry, oil & gas exploration industry, electrical vehicle charging stations, medical X-Ray Systems used in healthcare industry, fabrication works for locomotives, and wire harness division for their captive consumption in electrical control panels and for supply to air compressor industry. Their comprehensive solutions include design, process engineering, and manufacturing including fabrication, assembly, and testing facilities. It designs, programs, and assembles Electrical Control Panels and Cabinets comprising microcontrollers, programmable logic controllers, and SCADA systems.
50GF Score
Get the complete analysis for NSE:SAAKSHI
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAAKSHI has been successfully added to your 
